XML 62 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements Of Changes In Shareholders' Equity - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Surplus
Treasury stock
Retained earnings
Accumulated other comprehensive income (loss)
Series C preferred stock
Series C preferred stock
Preferred stock
Series C preferred stock
Common stock
Series C preferred stock
Surplus
Balance at beginning of period at Dec. 31, 2016 $ 2,695,617 $ 251,257 $ 51,978 $ 1,365,781 $ (4,589) $ 1,096,518 $ (65,328)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 257,682         257,682          
Other comprehensive income (loss), net of tax 23,493           23,493        
Cash dividends declared on common stock (30,765)         (30,765)          
Dividends on preferred stock (9,778)         (9,778)          
Stock-based compensation 12,858     12,858              
Conversion of Series C Preferred Stock to common stock               $ 0 $ (126,257) $ 3,121 $ 123,136
Common stock issued for:                      
Acquisitions 0                    
Exercise of stock options and warrants 24,074   813 23,261              
Restricted stock awards (397)   88 (88) (397)            
Employee stock purchase plan 2,530   36 2,494              
Director compensation plan 1,625   32 1,593              
Balance at end of period at Dec. 31, 2017 2,976,939 125,000 56,068 1,529,035 (4,986) 1,313,657 (41,835)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Cumulative effect adjustment from adoption | ASU 2018-02 0         2,974 (2,974)        
Net income 343,166         343,166          
Other comprehensive income (loss), net of tax (30,183)           (30,183)        
Cash dividends declared on common stock (42,787)         (42,787)          
Dividends on preferred stock (8,200)         (8,200)          
Stock-based compensation 13,496     13,496              
Common stock issued for:                      
Acquisitions 0                    
Exercise of stock options and warrants 11,466   299 11,359 (192)            
Restricted stock awards (456)   101 (101) (456)            
Employee stock purchase plan 2,523   31 2,492              
Director compensation plan 1,722   19 1,703              
Balance at end of period at Dec. 31, 2018 3,267,570 125,000 56,518 1,557,984 (5,634) 1,610,574 (76,872)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 355,697         355,697          
Other comprehensive income (loss), net of tax 42,194           42,194        
Cash dividends declared on common stock (56,910)         (56,910)          
Dividends on preferred stock (8,200)         (8,200)          
Stock-based compensation 11,304     11,304              
Common stock issued for:                      
Acquisitions 71,756   1,074 70,682              
Exercise of stock options and warrants 4,843   146 5,541 (844)            
Restricted stock awards (453)   150 (150) (453)            
Employee stock purchase plan 2,819   44 2,775              
Director compensation plan 2,161   19 2,142              
Balance at end of period at Dec. 31, 2019 $ 3,691,250 $ 125,000 $ 57,951 $ 1,650,278 $ (6,931) $ 1,899,630 $ (34,678)